Drunk From Pizza? Rare ‘Auto-Brewery Syndrome’ Turns Carbs Into Alcohol

Fecal transplants could stop the gut microbes and metabolic pathways that turn patients’ intestines into booze factories

Alcohol, and its effects post-ingestion, can be enjoyable for many people given the right time, place, and amount. That being said, pretty much everyone can agree that suddenly feeling drunk after eating a bagel or sandwich doesn’t sound very pleasant.

For people with auto-brewery syndrome, this nightmare scenario is reality. Their gut bacteria quite literally ferment carbohydrates into alcohol, causing intoxication without touching a drop of liquor. Now, researchers have finally identified the microbial culprits and biochemical pathways behind this bizarre condition. These findings could revolutionize treatment for patients who’ve been dismissed as secret drinkers for years.

Published in Nature Microbiology, the study examined 22 patients with clinically documented auto-brewery syndrome alongside 21 of their household partners. The research team, led by scientists at UC San Diego and Massachusetts General Hospital, discovered that specific bacteria and not yeast, as previously believed, are the primary troublemakers, producing pathological levels of alcohol through multiple fermentation pathways.

What Is Auto-Brewery Syndrome?

Auto-brewery syndrome, also called gut fermentation syndrome, remains poorly understood despite being described in medical literature for decades. Patients experience symptoms of intoxication, including slurred speech, loss of coordination, and memory problems, that mysteriously appear after consuming carbohydrates. Many visit multiple doctors only to be accused of hiding alcohol consumption, facing serious family, social, and legal consequences before finally receiving a diagnosis.

The current study is the first large-scale investigation into the microbiological profiles of patients with auto-brewery syndrome. During diagnostic testing, patients showed median peak blood alcohol concentrations of 73 mg/dL after consuming an oral glucose load, just under the U.S. legal driving limit of 80 mg/dL. Some patients reached much higher levels. When researchers collected stool samples during symptomatic “flares,” breathalyzer readings averaged 136 mg/dL with considerable variation, well above the legal limit for many patients.

Laboratory cultures told the story even more dramatically. Fecal samples from patients during flares produced a median of 14.47 mg/dL of ethanol after 24 hours of growth, compared to just 8.76 mg/dL during remission periods and 5.00 mg/dL from healthy household partners.

Bacteria Appear to Be the Primary Culprits in Auto-Brewery Syndrome

For years, medical case reports blamed yeast overgrowth for auto-brewery syndrome, giving it the nickname “drunkenness disease.” This new research points to bacteria as the major contributors in this patient cohort, though the role of fungi cannot be completely ruled out.

When researchers treated bacterial cultures with the broad-spectrum antibiotic chloramphenicol, ethanol production dropped significantly. The antifungal medication amphotericin B showed no significant overall effect, though three flare samples did show partial reduction in ethanol production. Genetic sequencing of the gut microbiome revealed minimal differences in fungal composition between patients and their household partners. Most tellingly, when researchers tried to grow fungi from stool samples, nothing appeared on culture plates.

“These findings suggest that gut bacteria are important contributors to ABS pathophysiology,” the researchers write. They note, however, that increased antifungal use after diagnosis may have suppressed fungal growth in some patients, meaning a potential role for fungi in certain cases cannot be completely ruled out.

The bacterial villains? Primarily members of the Proteobacteria phylum, including Escherichia coli and Klebsiella pneumoniae. These are common gut residents that have evolved impressive ethanol-producing capabilities. Patients with auto-brewery syndrome during symptomatic flares showed dramatically higher levels of Proteobacteria compared to household partners and healthy controls. Blood alcohol concentration directly correlated with Proteobacteria abundance.

Three Metabolic Highways to Intoxication

The research team used advanced metagenomic sequencing to identify not just which bacteria were present, but what they were doing. They discovered that patients with auto-brewery syndrome had enrichment of genes in three metabolic pathways known to produce ethanol.

The mixed-acid fermentation pathway allows bacteria like E. coli to convert glucose into ethanol and succinate. Nearly every enzyme in this pathway was over-represented in flare samples compared to remission and household partner samples from within the same household.

The heterolactic fermentation pathway metabolizes glucose through a different route, producing ethanol via acetyl phosphate as an intermediate. Again, patients showed dramatically higher gene counts for these enzymes during symptomatic periods.

The ethanolamine utilization pathway converts ethanolamine, a compound found in cell membranes, into ethanol. This pathway was also enriched in auto-brewery syndrome patients during flares.

Perhaps most revealing, researchers found increased genes for alcohol dehydrogenase activity in six key bacterial species: E. coli, K. pneumoniae, Alistipes putredinis, Ruminococcus gnavus, Blautia wexlerae, and Blautia obeum. The total gene counts for this enzyme, which catalyzes the final step in ethanol production, strongly correlated with patients’ blood alcohol concentrations.

When Good Bacteria Turn Bad

Interestingly, simply having high levels of Proteobacteria isn’t enough to cause auto-brewery syndrome. When researchers tested fecal samples from patients with inflammatory bowel disease, a condition also characterized by Proteobacteria overgrowth, they found no increase in ethanol production compared to healthy controls.

Something else must be happening in auto-brewery syndrome patients beyond just Proteobacteria overgrowth. The research points to specific bacterial strains with enhanced ethanol-producing and ethanol-tolerant capabilities. When scientists isolated E. coli strains from one patient, they found these bacteria could grow in much higher ethanol concentrations than E. coli from a healthy donor.

Microbiome analysis also revealed that auto-brewery syndrome patients had lower levels of beneficial bacteria during flares, particularly species from the Clostridiales order like Ruminococcus bromii and Coprococcus eutactus. These bacteria are known to produce short-chain fatty acids that support gut health. Meanwhile, samples showed enrichment of genes for compounds that certain bacteria use as electron acceptors during anaerobic respiration, the same oxygen-free conditions that favor alcohol fermentation.

The Acetate Connection

Metabolic analysis of fecal samples revealed another piece of the puzzle: elevated acetate levels in auto-brewery syndrome patients. Acetate, a short-chain fatty acid, is both a product of ethanol metabolism and a substrate that can be converted back into the building blocks for ethanol production.

Fecal acetate levels strongly correlated with patients’ blood alcohol concentrations. They also correlated positively with abundance of Escherichia and Blautia bacteria, and negatively with Akkermansia (a beneficial bacterium associated with metabolic health), creating a vicious cycle where ethanol-producing bacteria create an intestinal environment that favors even more ethanol production.

Fecal Transplant Offers Hope for Auto-Brewery Syndrome

Perhaps the most encouraging finding comes from the detailed case study of one patient who received fecal microbiota transplantation (FMT) as treatment. After years of suffering from auto-brewery syndrome that began following multiple courses of ciprofloxacin antibiotics for prostate issues, the patient agreed to experimental treatment with donor fecal capsules.

After the first FMT, which involved mild antibiotic pretreatment focused on gut bacteria, the patient experienced remarkable improvement for three months. This included better wakefulness, less drowsiness, reduced irritability, with family members noting his personality had essentially returned to normal. Unfortunately, symptoms eventually relapsed.

Nine months later, the patient received a second, more aggressive FMT protocol. This time, doctors used systemic antibiotics that could reach beyond the intestinal lumen to target bacteria in biofilms and less active metabolic states. The patient also received monthly FMT maintenance doses for six months, along with potato starch (a resistant starch that feeds beneficial bacteria) and a commercial probiotic combination.

After this second treatment, the patient remained in remission for over 16 months, with no symptoms and no detectable blood alcohol levels. He even successfully reintroduced carbohydrates into his diet.

Microbiome data told the success story at the molecular level. Before FMT, during symptomatic flares, the patient’s gut was dominated by E. coli and showed high levels of ethanol-producing fermentation pathways. After the second FMT, his gut microbiota clustered closely with the healthy donor’s microbiome and remained stable. The abundance of E. coli, the enrichment of fermentation pathways, and markers of liver injury all decreased dramatically.

Detailed strain-level analysis provided molecular confirmation of the treatment’s success. The researchers report that the patient’s clinical state tracked with microbiome changes: as his gut bacteria shifted away from his pre-treatment diseased profile and toward the healthy donor’s profile, his symptoms improved and laboratory markers normalized. The abundance of E. coli, the enrichment of fermentation pathways, and markers of liver injury all decreased dramatically after the second FMT.

Beyond Auto-Brewery Syndrome

While this study focuses on patients with extreme gut microbial alcohol production sufficient to cause detectable blood alcohol levels, the reach may extend much further. Other research has reported low-level gut microbial ethanol production in patients with diabetes and implicated it in the development of metabolic dysfunction-associated fatty liver disease (formerly called nonalcoholic fatty liver disease).

In these cases, the ethanol levels are low enough that the liver completely metabolizes them before they reach systemic circulation, so patients don’t experience intoxication. However, the constant exposure of liver tissue to gut-derived ethanol may contribute to liver damage over time. This raises broader questions about how prevalent pathological gut ethanol production might be in the general population and whether it plays an unrecognized role in metabolic disease.

The Road Ahead For Auto-Brewery Syndrome Patients

Currently, there’s no consensus treatment for auto-brewery syndrome. Patients typically manage the condition through severe carbohydrate restriction, periodic antibiotic courses, and sometimes antifungal medications based on the older assumption about yeast overgrowth.

These findings point to more targeted approaches. Antibiotics that specifically target Proteobacteria, FMT from healthy donors, and possibly probiotic interventions to restore beneficial bacterial populations could all prove effective. The researchers specifically note that enhancing bacteria that metabolize ethanol to acetate, rather than producing ethanol from acetate, might help tip the metabolic balance away from intoxication.

Future research will need to identify the exact genomic features that make certain bacterial strains particularly adept at producing ethanol and tolerating high alcohol environments. Understanding these mechanisms could lead to targeted therapeutics or even engineered probiotic bacteria designed to outcompete ethanol-producing strains.

For patients suffering with auto-brewery syndrome, this research offers validation that their condition is real, mechanistically understood, and potentially treatable.

---

Disclaimer: This article is for informational purposes only and is not intended as medical advice. If you experience symptoms of auto-brewery syndrome or unexplained intoxication after eating carbohydrates, consult a qualified healthcare provider for proper diagnosis and treatment.

---